$1.56
0.04 (+2.89%)
DUSA Pharmaceuticals, Inc. (DUSA)
CAPS Rating:
A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.
RSS Headlines
Fool UK
